Tubular Omega‐3 Fatty Acid Receptor FFAR4 Deficiency Aggravated Renal Aging and Chronic Kidney Disease
Aging Cell · 2026-06 · 25 (6)
DOI: 10.1111/acel.70546 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, online erschienen am 23.05.2026. Verfasst von Letian Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Institute of Kidney Diseases, West China Hospital of Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Receptors, G-Protein-Coupled, Aging, Kidney Tubules. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Sichuan Science and Technology Program, the Postdoctor Research Fund from West China Hospital of Sichuan University.
Abstract (Originalsprache)
Aging leads to renal function decline and increases the risk of chronic kidney disease (CKD). Omega‐3 polyunsaturated fatty acids (PUFAs) are essential fatty acids for humans, exerting their functions via free fatty acid receptor 4 (FFAR4). Clinical studies indicate that omega‐3 PUFAs supplementation shows benefits for the elderly population and CKD patients, but these results remain controversial. Herein, we found that omega‐3 PUFAs alleviated renal fibrosis and tubular senescence in aged mice, adenine diet‐induced CKD mice, and unilateral ureteral obstruction (UUO) mice. Meanwhile, omega‐3 fatty acid receptor FFAR4 expression in tubular epithelial cells (TECs) were down‐regulated in the old population and CKD patients, positively correlated with renal dysfunction. Systemic or TEC‐specific knockout of FFAR4 aggravated renal aging and CKD in mice. Mechanically, FFAR4 agonism increases the production of endogenous PPARγ activator 15‐deoxy‐∆12,14‐Prostaglandin J2 (15d‐PGJ2), and improves PPARγ‐dependent tubular epithelial cell senescence, which was indicated by anti‐aging marker Klotho expression, senescence‐associated β‐galactosidase (SA‐β‐gal) activity, and profibrotic factor TGF‐β1 secretion. The study demonstrated a novel role of FFAR4 from senescent TECs on fibroblast activation via paracrine effects and highlighted the therapeutic effects of omega‐3 PUFAs with their receptor FFAR4 as an attractive drug target against renal aging and CKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Institute of Kidney Diseases, West China Hospital of Sichuan University, Chengdu, China.
- Department of West Outpatient, State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & West China Hospital of Stomatology, Sichuan University, Chen…
Förderung
- National Natural Science Foundation of China
- Sichuan Science and Technology Program
- the Postdoctor Research Fund from West China Hospital of Sichuan University
- the Postdoctoral Fellowship Program of CPSF
- the 1.3.5 project for disciplines of excellence from West China Hospital of Sichuan University
Zitieren
APA
Yang, L., Tang, L., Li, J., Liu, D., Hu, C., Guo, F., Lin, L., Huang, R., Fu, P., & Ma, L. (2026). Tubular Omega‐3 Fatty Acid Receptor FFAR4 Deficiency Aggravated Renal Aging and Chronic Kidney Disease. Aging Cell, 25(6). https://doi.org/10.1111/acel.70546
Vancouver
Yang L, Tang L, Li J, Liu D, Hu C, Guo F, et al. Tubular Omega‐3 Fatty Acid Receptor FFAR4 Deficiency Aggravated Renal Aging and Chronic Kidney Disease. Aging Cell. 2026;25(6). doi:10.1111/acel.70546
BibTeX
@article{Yang2026,
author = {Yang, Letian and Tang, Lei and Li, Jian and Liu, Dekai and Hu, Chunchun and Guo, Fan and Lin, Lin and Huang, Rongshuang and Fu, Ping and Ma, Liang},
title = {Tubular Omega‐3 Fatty Acid Receptor FFAR4 Deficiency Aggravated Renal Aging and Chronic Kidney Disease},
journal = {Aging Cell},
year = {2026},
volume = {25},
number = {6},
doi = {10.1111/acel.70546}
}
EUVIMED